Every day across the globe, advanced treatments offer new hope for patients. New advances in medicine may treat or cure diseases that were disabling, even terminal.
But they also present new challenges for policymakers and governments, who must ask: How will these treatments be approved? Regulated? Paid for? To answer these questions, policymakers need to hear from those who will be directly affected — patients and physicians.
That’s why GAfPA works internationally to educate, empower and mobilize physicians and patient advocates. Their unique insight can guide policymakers to make informed decisions about value, safety, cost and, ultimately, patient access.
Partnerships with individuals, patient advocacy groups and international organizations allow GAfPA to expand its reach and amplify its efforts. These partnerships may work to create and distribute educational materials, or perhaps to organize and orchestrate advocacy events. GAfPA welcomes the opportunity to partner with like-minded organizations and individuals.
October 5, 2016 — October 6, 2016
At the Nordic Patient Advocacy Workshop, the goal is to provide or improve basic understanding of the science and issues associated with biological medicines and biosimil.
November 15, 2016 — November 15, 2016
The conference aims to support patients’ right to information and knowledge, to ensure their access to drugs and to health care and to include them in the decision making processes.